The Federal Trade Commission this month released an "interim" report concerning pharmacy benefit managers, administrative service providers that negotiate pricing arrangements with pharmaceutical manufacturers for health plans, develop reimbursement terms for pharmacies and create formularies. The FTC alleges these PBMs have uniquely abused market conditions, creating anti-competitive effects.